Ananthakrishnan Ramani

662 total citations
18 papers, 392 citations indexed

About

Ananthakrishnan Ramani is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Ananthakrishnan Ramani has authored 18 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Ananthakrishnan Ramani's work include Antimicrobial Resistance in Staphylococcus (3 papers), Diabetic Foot Ulcer Assessment and Management (2 papers) and Antifungal resistance and susceptibility (2 papers). Ananthakrishnan Ramani is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Diabetic Foot Ulcer Assessment and Management (2 papers) and Antifungal resistance and susceptibility (2 papers). Ananthakrishnan Ramani collaborates with scholars based in United States, India and Switzerland. Ananthakrishnan Ramani's co-authors include Biplab K. Saha, Amit Chopra, Woon H. Chong, Rama Ramani, C. R. Srinivas, P G Shivananda, Michael Fried, Joy Peter, Alena Jandourek and Joseph K. Lim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and CHEST Journal.

In The Last Decade

Ananthakrishnan Ramani

17 papers receiving 374 citations

Peers

Ananthakrishnan Ramani

EPIDE

HEPAT

SURGE

A. I. M. Hoepelman Netherlands

Liliana Preoțescu Romania

Eva Romá Spain

Marta Herrero Spain

G. Gubertini Italy

Ronald J. Servi United States

Maria Pirounaki Greece

Marilyn M. Wagener United States

Ishani Bora India

Miguel Sierra‐Hoffman United States

A. I. M. Hoepelman Netherlands

Ananthakrishnan Ramani

172 ×0.9

EPIDE

108 ×0.6

49 ×0.5

HEPAT

23 ×0.5

SURGE

5 ×0.1

Citations per year, relative to Ananthakrishnan Ramani Ananthakrishnan Ramani (= 1×) peers A. I. M. Hoepelman

Countries citing papers authored by Ananthakrishnan Ramani

Since Specialization

Citations

This map shows the geographic impact of Ananthakrishnan Ramani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ananthakrishnan Ramani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ananthakrishnan Ramani more than expected).

Fields of papers citing papers by Ananthakrishnan Ramani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ananthakrishnan Ramani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ananthakrishnan Ramani. The network helps show where Ananthakrishnan Ramani may publish in the future.

Co-authorship network of co-authors of Ananthakrishnan Ramani

This figure shows the co-authorship network connecting the top 25 collaborators of Ananthakrishnan Ramani. A scholar is included among the top collaborators of Ananthakrishnan Ramani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ananthakrishnan Ramani. Ananthakrishnan Ramani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ramani, Ananthakrishnan, et al.. (2023). Successful Treatment of Bilateral Renal Mucormycosis With Isavuconazole: A Case Report. Cureus. 15(7). e42219–e42219. 1 indexed citations

Ramani, Ananthakrishnan, et al.. (2022). Polymicrobial anaerobic sepsis due to Bacteroides fragilis, Eggerthella lenta, Ruminoccocus gnavus, and Bilophila wadsworthia in a patient with myeloproliferative neoplasm. Anaerobe. 78. 102641–102641. 7 indexed citations

Chong, Woon H., Biplab K. Saha, Ananthakrishnan Ramani, & Amit Chopra. (2021). State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 49(4). 591–605. 113 indexed citations

Peredo-Wende, Ruben, et al.. (2021). Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection. Microbiology Spectrum. 9(2). e0089021–e0089021. 2 indexed citations

Zahra, Fatima Tuz, et al.. (2020). Hemorrhagic Cystitis Secondary to Adenovirus and BK Virus Infection in a Diffuse Large B-Cell Lymphoma Patient with Recent CAR T-Cell Therapy. SHILAP Revista de lepidopterología. 2020. 1–4. 4 indexed citations

Johnson, Leonard B., et al.. (2019). Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience. BMC Infectious Diseases. 19(1). 183–183. 19 indexed citations

Chieng, Hau, et al.. (2019). AN UNUSUAL PRESENTATION OF DISSEMINATED NOCARDIOSIS: ACUTE COMPARTMENT SYNDROME. CHEST Journal. 156(4). A762–A763.

Wang, Gary P., Norah A. Terrault, Jacqueline D. Reeves, et al.. (2018). Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Scientific Reports. 8(1). 3199–3199. 18 indexed citations

Vázquez, José A., et al.. (2015). Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit. Therapeutics and Clinical Risk Management. 11. 557–557. 5 indexed citations

10.

Gordon, Stuart C., Andrew J. Muir, Joseph K. Lim, et al.. (2014). Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET. Journal of Hepatology. 62(2). 286–293. 72 indexed citations

11.

Ramani, Ananthakrishnan, George Udeani, J. D. Evans, et al.. (2014). Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience. Journal of Chemotherapy. 26(4). 229–234. 18 indexed citations

12.

Lipsky, Benjamin A., Chad Cannon, Ananthakrishnan Ramani, et al.. (2014). Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience. Diabetes/Metabolism Research and Reviews. 31(4). 395–401. 23 indexed citations

13.

Ramani, Ananthakrishnan, et al.. (1995). AMOEBIC LIVER ABSCESS. A PROSPECTIVE STUDY OF 200 CASES IN A RURAL REFERRAL HOSPITAL IN SOUTH INDIA. 7 indexed citations

14.

Ramani, Rama, et al.. (1993). MOLDS IN ONYCHOMYCOSIS. International Journal of Dermatology. 32(12). 877–878. 50 indexed citations

15.

Ramani, Ananthakrishnan, et al.. (1993). Hemorheologic Approach in the Treatment of Diabetic Foot Ulcers. Angiology. 44(8). 623–626. 5 indexed citations

16.

Ramani, Ananthakrishnan, et al.. (1993). Ultrasound-guided needle aspiration of amoebic liver abscess. Postgraduate Medical Journal. 69(811). 381–383. 26 indexed citations

17.

Ramani, Ananthakrishnan, et al.. (1990). Electrocardiographic Abnormalities in Cerebrovascular Accidents. Angiology. 41(9). 681–686. 15 indexed citations

18.

Nayak, Sudhakar S., et al.. (1988). Serum apoproteins A and B and the lecithin: Cholesterol acyl transferase activities in liver cirrhosis and hepatic coma patients. Biochemical Medicine and Metabolic Biology. 40(3). 299–304. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact